(19)
(11) EP 1 534 728 A2

(12)

(88) Date of publication A3:
31.03.2005

(43) Date of publication:
01.06.2005 Bulletin 2005/22

(21) Application number: 03729073.1

(22) Date of filing: 20.05.2003
(51) International Patent Classification (IPC)7C07H 21/04, A61K 48/00, C12N 15/00
(86) International application number:
PCT/US2003/016084
(87) International publication number:
WO 2003/099215 (04.12.2003 Gazette 2003/49)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 20.05.2002 US 381857 P

(71) Applicant: Pharmacia Corporation
St. Louis, MO 63006 (US)

(72) Inventors:
  • CROSBY, Seth, D.
    St. Charles, MO 63304 (US)
  • NALSETH, Amy, E.
    St. Louis, MO 63006 (US)

(74) Representative: Boxall, Sarah Jane 
Pfizer LimitedEuropean Pharma Patent DepartmentRamsgate Road
Sandwich, Kent CT13 9NJ
Sandwich, Kent CT13 9NJ (GB)

   


(54) ANTISENSE MODULATION OF GLUCOCORTICOID RECEPTOR EXPRESSION